Neurological
Product Name |
Application |
Region |
ME011-MMR |
Mismatch repair genes (MMR) |
MLH1, MSH2, MSH6, MLH3, MSH3, PMS2, MGMT |
ME012-MGMT-IDH1-IDH2 |
Gliomas |
MGMT, IDH1, IDH2 |
ME029-FMR1/AFF2 |
Fragile X |
FMR1, AFF2 |
P015-MECP2 |
RETT syndrome |
MECP2, Xq28 |
P022 -PLP1 |
Pelizaeus-Merzbacher disease (PMD) |
PLP1 Xq22 |
P025-Canavan |
Canavan disease |
ASPA, 17p13 |
P041-ATM-1 CE |
Ataxia-Telangiectasia (AT) |
ATM 11q23 |
P042-ATM-2 CE |
Ataxia-Telangiectasia (AT) |
ATM 11q23 |
P044-NF2 |
Neurofibromatosis type 2 (NF2) |
NF2 22q12 |
P046-TSC2 |
Tuberous Sclerosis |
TSC2 16p13.3 |
P049-SLC6A8 - ABCD1 |
Creatine transporter, x-linked |
SLC6A8, Xq28 |
P051-Parkinson mix 1 |
Parkinson disease, familial |
PARK2 6q25.2, SNCA 4q21, Pink1, Park7 1p36 |
P052-Parkinson mix 2 |
Parkinson disease, familial |
PARK2 6q25.2, UCHL1 4p14, GCH1 14q22.1, LRRK2 12q12 |
P059-Dystonia |
Dystonia |
PRKRA; THAP1; TOR1A; ATP1A3 |
P061-Lissencephaly |
Lissencephaly |
LIS1, DCX, POMT1, POMGnT1, FLNA |
P063-FHIT-WWOX |
Diverse tumour types, epileptic encephalopathy |
FHIT (3p14.2) and WWOX (16q23.1) |
P071-LMNB1-PLP1-NOTCH3 |
Leukodystrophy |
LMNB1 5q23.2, PLP1 Xq22.2, NOTCH3 19p13.12 |
P075-TCF4-FOXG1 |
Pitt-Hopkins syndrome, Congential variant of Rett syndrome |
TCF4, FOXG1 |
P081-NF1 mix 1 |
Neurofibromatosis |
NF1 17q11.2 |
P082-NF1 mix 2 |
Neurofibromatosis |
NF1 17q11.2 |
P088-Oligodendroglioma 1p-19q |
Oligodendroglioma |
1p, 19q, IDH1/2, CDKN2A/2B |
P098-Wilson |
Wilson disease |
ATP7B 13q14.3 |
P099-GCH1-TH-SGCE |
Dopa-responsive dystonia, Segawa disease; Myoclonus-dystonia syndrome |
TH 11p15.5, GCH114q22, SGCE 7q21 |
P103-DPYD |
Dihydropyrimidine dehydrogenase (DPYD) deficiency |
DPYD 1p22 |
P105-Glioma-2 |
Glioma, malignant |
EGFR, TP53, PTEN + various other |
P107-Neurometabolic |
Neurometabolic disorders |
ASPA, MLC1, MLYCD, D2HGDH, L2HGDH |
P120-PANK2/PLA2G6 |
Neurodegeneration with brain iron accumulation (NBIA) |
PANK2 20q13, PLA2G6 22q13 |
P122-NF1-area |
Neurofibromatosis |
NF1 17q11.2 |
P124-TSC1 |
Tuberous Sclerosis |
TSC1 9q34 |
P130-CCM mix-1 |
Cerebral Cavernous Malformations (CCM) |
CCM 7q21 |
P131-CCM mix-2 |
Cerebral Cavernous Malformations (CCM) |
CCM 7q21 |
P137-SCN1A |
Epilepsy |
SCN1A 2q24.3 |
P138-SLC2A1-STXBP1 |
Glut1 deficiency syndrome |
SLC2A1, STXBP1 |
P165-HSP |
Spastic paraplegia, hereditary (HSP) |
SPG3A 14q21, SPAST 2p22 |
P166-KCNQ2 |
Benign familial neonatal convulsion (BFNC) |
KCNQ2 20q13.33 |
P170-APP |
Alzheimer disease, early-onset |
APP 21q21.3 |
P187-HPE |
Holoprosencephaly (HPE) |
PTCH, SHH, ZIC2, SIX3, TGIF TMEM1, FBXW11 |
P189-CDKL5 |
Rett syndrome, atypical |
CDKL5 Xp22, NTNG1 1p13.3, ARX Xp21.3 |
P197-KCNQ3 |
Neonatal convulsions type 2, familial (BFNC2), Epilepsy benign neonatal type 2 (EBN2) |
KCNQ3 8q24.22; CHRNA4 20q13.33; EPM2A 6q24.3; NHLRC1 6p22.3; CHRNB2 1q21.3; KCNQ1 11p55.5-4 |
P199-HEXA |
Tay-Sachs Disease |
HEXA 15q23 |
P211-HSP region |
Hereditary Spastic Paraplegias (HSPs) region |
SPAST 2p22, NIPA1 15q11 |
P213-HSP mix-2 |
Hereditary spastic paraplegias (HSPs) |
REEP1 (SPG31) 2p11.2, SPG7 16q24.3 |
P226-SDH |
Paragangliomas (PGL) |
SDHD 11q23.1, SDHB 1p36.1, SDHC 1q23.3 |
P251-NB mix 1 |
Neuroblastoma |
1p36, 3p22/3p21.3 and 11q23 |
P252-NB mix 2 |
Neuroblastoma |
2p24.1/MYCN, 2q33, 17p13/TP53, 17q |
P253-NB mix 3 |
Neuroblastoma |
Chromosomes 4, 7, 9, 12, 14 |
P254-PSEN1 |
Alzheimer's disease (AD) |
PSEN1 14q24.2 |
P267-Dandy-Walker |
Dandy-Walker Malformation (DWM) |
ZIC1, ZIC4 3p2, VLDLR 9p24 |
P274-SLC6A5/GLRA1/GLRB |
Startle disease, Hyperekplexia |
GLRB 4q32.1, GLRA1 5q33.1, SLC6A5 11p15.1 |
P275-MAPT-GRN |
Alzheimer's disease, Pick's disease, frontotemporal dementia, cortico-basal degeneration, progressive supranuclear palsy |
MAPT 17q21 |
P279-CACNA1A |
Episodic ataxia 2, Familial hemiplegic migraine |
CACNA1A |
P295-SPRED1 |
SPRED1 |
SPRED1 15q14 |
P301-Medulloblastoma mix 1 |
Medulloblastoma |
Chr. 6, Chr. 14, Chr. 16, Chr. 17. |
P302-Medulloblastoma mix 2 |
Medulloblastoma |
Chr. 2, Chr. 3, Chr. 7, Chr. 9 |
P303-Medulloblastoma mix 3 |
Medulloblastoma |
Chr. 1, Chr. 4, Chr. 5, Chr. 8, Chr. 10, Chr. 20 |
P306-SPG11 |
Hereditary spastic paraplegia (HSP or SPG) |
SPG11 or KIAA1840 15q21.1 |
P307-SEPT9 |
Hereditary neuralgic amyotrophy (HNA) |
SEPT9 17q25.3 |
P316-Recessive Ataxias |
Recessive Ataxias |
SETX, APTX, FXN. |
P326-LARGE |
Walker-Warburg Syndrome |
LARGE, FKTN, POMT2 |
P330-PCDH19 |
Epilepsy (EFMR) |
PCDH19 |
P336-UBE3A |
Angelman |
UBE3A, MTHFR, GABRB3 |
P337-TSC2 |
Tuberous sclerosis |
TSC2 gene, 16p13.3 |
P339-SHANK3 |
Autism Spectrum Disorder |
SHANK3 22q13.33 |
P343-Autism-1 |
Autism |
15q11-13: UBE3A, GABRB3; 16p11; SHANK3 22q13 |
P348-ATP1A2-CACNA1A |
Migraine |
1q23, 19p13 |
P355-Microcephaly |
Primary Microcephaly |
MCPH1, ASPM, CDK5RAP2, CENPJ, STIL |
P370-BRAF-IDH1-IDH2 (basic research) |
Gliomas |
BRAF, IDH1, IDH2, FGFR1, MYB, MYBL1, CDKN2A |
P388-AGS |
Aicardi-Goutieres Syndrome |
RNASEH2A, B & C genes, TREX1, SAMHD1 |
P395-MEF2C-FOXG1 |
mental retardation |
MEF2C 5q14.3, FOXG1 14q12 |
P396-SHANK2 |
Autism-spectrum disorder |
SHANK2 11q13.3 |
P398-CASK |
X-linked mental retardation and MICPCH |
CASK |
P408-ADLTE-LGI1 |
Autosomal Dominant Lateral Temporal Lobe Epilepsy, ADLTE |
ADAM22, GPR98, KCNA1, KCNA4, KCNAB1, LGI1, PDYN |
P410-GRIN2A GRIN2B |
epilepsy, mental retardation |
16p13.2 GRIN2A, 12p13.1 GRIN2B |
P411-Porphyria mix 1 |
Porphyrias |
ALAD, HMBS, PPOX |
P412-Porphyria mix 2 |
Porphyrias |
FECH, UROS, UROD, CPOX |
P427-PDHA1 |
Leigh Syndrome |
X-chromosome |
P429-SDHA-MAX |
Paraganglioma and pheochromocytoma |
5p15.3 and 14q23.3 |
P437-Familial MDS-AML |
Familial MDS-AML |
RUNX1, CEBPA, GATA2, TERT, TERC |
P441-SACS |
ARSACS (autosomal recessive spastic ataxia of Charlevoix-Saguenay) |
3q12.12 |
P446-GALC |
Krabbe Disease |
14q31.3 |
P447-HPRT1 |
Lesch-Nyhan syndrome |
Xq26.1 |
P455-LZTR1 |
Schwannomatosis |
22q11.21 |
P470-NCL |
Neuronal Ceroid Lipofuscinoses/Batten Disease |
01p34.2, 08p23.3, 11p15.4, 15q23, 16p11.2 |
P471-EOFAD |
Early-Onset Familial Alzheimer's Disease (EOFAD) |
01q42.13; 14q24.2; 21q21.3 |